2/17/15 - m-spike 1.5 to start study
- began SAR650984 study.
- Includes 40mg dex and 25mg revlimid.
- Had a pretty serious reaction during infusion.
- Throat tightened (hard to swallow)
- head stopped up, and chest tightness
- Stopped treatment for an hour but then restarted and everything was fine.
- Zometa treatment
2/24/15 - treatment, noticed immediately less pain in feet and knees, result of taking dex again.
3/03/15 - treatment
3/10/15 - treatment
3/17/15 - m-spike 1.0 after 1 month of treatment
4/17/15 - m-spike 0.7 after 2 months of treatment
5/17/15 - m-spike 0.6 after 3 months of treatment
5/14/15 - 5/18/15 admitted to hospital with pneumonia and para influenza
6/17/15 - m-spike 0.6 after 4 months of treatment
- Zometa treatment
7/17/15 - m-spike 0.6 again
8/17/15 - m-spike 0.4 !!
9/01/15 - m-spike 0.5
- Zometa treatment
10/01/15 - m-spike 0.3
11/01/15 - m-spike 0.3
11/24/15 - m-spike 0.3
- Zometa treatment
- SAR650984 is given a name: Isatuximab.
- daratumumab (Darzalex) approved by FDA (close to Isatuximab)
- Ixazomib (Ninlaro) (next gen of velcade, carfilzamib, but in pill form) approved by FDA
- Elotuzumab (Empliciti) approved by FDA
12/22/15 - m-spike 0.2
